Torsten Peter Vahl, MD

Cardiovascular Disease
Interventional Cardiology
More specialties
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Torsten P. Vahl, MD, is the Director of Translational Research and an attending physician at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. He is also an Assistant Professor of Medicine at Columbia University Irving Medical Center.

Dr. Vahl is board-certified in interventional cardiology, cardiovascular disease, and cardiovascular computed tomography. He specializes in the percutaneous treatment of coronary artery disease and structural heart disease. His primary focus areas include transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair and replacement (TMVR), transcatheter tricuspid valve repair and replacement (TTVR) and left atrial appendage closure.

Dr. Vahl has led several preclinical and first-in-human studies through his work with the Cardiovascular Research Foundation. He is serving as the national principal investigator for the ALIGN-AR trial, following his involvement in the device's preclinical research. He also proctors other interventional cardiologists on TAVR using the Trilogy valve and on TMVR with the Cephea valve. In the area of left atrial appendage closure, he has helped develop an intracardiac echo program that enables patients to undergo the procedure without general anesthesia or transesophageal echocardiography (TEE).

Dr. Vahl earned his medical degree from Philipps-Universität in Marburg, Germany. He completed his residency in internal medicine and his fellowship in cardiovascular disease at Mount Sinai Medical Center in New York City. He then completed fellowships in interventional cardiology and structural interventions at Columbia University Irving Medical Center.

Areas of Expertise / Conditions Treated

  • Acute Coronary Syndrome
  • Atrial Fibrillation
  • Atrial Septal Defect
  • Heart Disease
  • Heart Valve Disease
  • Heart Valve Repair
  • Heart Valve Replacement
  • Left Atrial Appendage Closure
  • Minimally Invasive Valve Repair
  • Mitral Valve Repair
  • Mitral Valve Replacement/Repair
  • Patent Foramen Ovale (PFO)
  • Stenting Coronary Arteries
  • TAVR (Transcatheter Aortic Valve Replacement)

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Administrative Titles

  • Director, Translational Research at Columbia Interventional Cardiovascular Care
  • Director, Left Atrial Appendage Program

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Westchester

Languages

  • German

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

ElderServe

  • Special Needs

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Healthspring (Cigna Medicare)

  • Medicare Managed Care

Horizon Blue Cross Blue Shield

  • EPO - New York Services
  • POS - New York Services
  • PPO - New York Services

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Before your appointment, please contact the doctor’s office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.

Credentials & Experience

Education & Training

  • MD, 1998 Philipps University, Marburg (Germany)
  • 1998 Philipps-Universitaet Marburg
  • Internship: Mount Sinai Medical Center
  • Residency: Mount Sinai Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Interventional Cardiology
  • Cardiovascular Disease
  • Internal Medicine

Research

Selected Publications

  1. Makkar RR, Thourani VH, Vahl TP, Yadav PK, McCabe JM, George I, Satler L, Chetcuti S, Daniels DV, Waggoner T, Whisenant B, Russo M, Summers M, Garcia S, Frisoli T, Ramana RK, Stinis C, Golwala H, Zahr F, Greenbaum A, Rovin J, Sanchez C, Szerlip M, Deeb GM, Amoroso N, Patel D, Fahy M, Ranard LS, Gupta A, Chakravarty T, Skaf S, Chuang M, Kodali SK, Figulla HR, Treede H, Baldus S, Pinto DS, Leon MB; ALIGN-AR Investigators. Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study. Lancet. 2025 Nov 16:S0140-6736(25)02215-9. doi: 10.1016/S0140-6736(25)02215-9.
  2. Zhang K, Tao H, Zhu D, Yue Z, Hu S, Wu Y, Yan N, Hu Y, Liu S, Liu M, Vahl TP, Ranard LS, Cheng X, Romanov A, Liu J, Zhang SW, Li Y, Lu C, Shen M, Lewis A, Huang K, Cheng K. Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction. Science. 2026 Mar 5;391(6789):edau9394. doi: 10.1126/science.adu9394. Epub 2026 Mar 5.
  3. Vahl TP, Thourani V, Makkar R, Hamid N, Khalique OK, Daniels D, McCabe JM, Satler L, Russo M, Cheng W, George I, Aldea G, Sheridan B, Kereiakes D, Golwala H, Zahr F, Chetcuti S, Yadav P, Kodali SK, Treede H, Baldus S, Amoroso N, Ranard LS, Pinto DS, Leon MB. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study. Lancet 2024 Apr 13;403(10435):1451-1459. doi: 10.1016/S0140-6736(23)02806-4. Epub 2024 Mar 26
  4. Ranard LS, Cheng Y, Yi G, Ordanes D, McBride M, Butziger J, Forde S, Righini G, Denti P, Vahl TP. Procedural performance and healing response of a novel low profile transseptal transcatheter mitral valve replacement system. Eurointervention. 2024; 20(4): e261-e263
  5. Ranard LS, Guber K, Khalique OK, Leb J, Hamid N, Donald E, Hahn RT, Forman J, Ng V, Leon MB, Sommer R, Vahl TP. Improved Left Atrial Appendage Closure With the New-Generation WATCHMAN FLX by Cardiac Computed Tomography Angiography at 45 Days Postimplant. Circ Cardiovasc Interv. 2022 Apr;15(4):e011727. doi: 10.1161/CIRCINTERVENTIONS.121.011727. Epub 2022 Mar 22.
  6. Vahl TP, Grogan A, Cheng Y, Yi G, von Oepen R, Khalique OK, Wallace DT, Modine T, Granada JF. Experimental Evaluation of a Novel Percutaneous Transseptal Catheter-Based Mitral Valve Replacement Technology. Circ Cardiovasc Interv. 2019 Sep;12(9):e008002. doi: 10.1161/CIRCINTERVENTIONS.119.008002.

For a complete list of publications, please visit PubMed.gov.

Back to top